Strategies for the selection of medicinal plants to be studied;Estrategias en la selección de las plantas medicinales a investigar

Revista Cubana de Plantas Medicinales

Volumn 13, Issue 3, 2008, Pages

  Abreu Guirado, Orlando A ^a   Cuéllar Cuéllar, Armando ^b  

^a UNIVERSIDAD DE CAMAGÜEY   (Cuba)

^b INSTITUTO DE FARMACIA Y ALIMENTOS   (Cuba)

Author keywords

Ethnobotany; Ethnopharmacology; Medicinal plant selection; Pharmacological assays; Photochemistry

Indexed keywords

EID: 56849131084     PISSN: 10284796     EISSN: 10284796     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Hammond PM. The record to date: described species. En: Heywood VH. Watson RT. Eds. Global Biodiversity Assessment. Cambridge: Cambridge University Press; 1995. p. 113-38. [Links]
2. Cragg GM, Newman DJ, Snader KM. Natural products in drug discovery and development. J Nat Prod. 1997;60:52-60. [Links]
3. Myers N, Mittermeler RA, Mittermeler CG, Fonseca GAB, Kent J. Biodiversity hotspots for conservation priorities. Nature. 2000;403:853-8. [Links]
4. Soejarto DD, Fonga HHS, Tana GT, Zhang HJ, Ma CY, Franzblau SG, et al. Ethnobotany/ethnopharmacology and mass bioprospecting: Issues on intellectual property and benefit-sharing. J Ethnopharmacol. 2005;100(1-2):5-22. [Links]
5. Borris RP. The quest for new biologically active natural products. En: Hostettmann K, Gupta M, Marston A, editors. Chemistry, biological properties of medicinal plants from the Americas. Panama City, Panama: Proceeding of the IOCD/CYTED Symposium 23-26 February 1997;1999. p. 43-59. [Links]
6. Cordell GA, Colvard MD. Some thoughts on the future of ethnopharmacology. J Ethnopharmacol. 2005;100(1-2):5-14. [Links]
7. Elisabetsky E, Moraes JAR. Ethnopharmacology: a technological development strategy. First Internat Cong Ethnobiol. 1988;2:111-8. [Links]
8. Maureen R. Seeking for new drugs. C & EN. 1997;7:14-29. [Links]
9. Martin GJ. Etnobotánica. Manual de Métodos. Montevideo: Editorial Nordan_Comunidad; 2000. p. 240. [Links]
10. Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environm Health Perspect. 2001;109:69-75. [Links]
11. Basso LA, Pereira da Silva LH, Fett-Neto AG, de Azevedo Junior WF, de Souza Moreira I, Palma MS, et al. The use of biodiversity as source of new chemical entities against defined molecular targets for treatment of malaria, tuberculosis, and T-cell mediated diseases. Mem Inst Oswaldo Cruz. 2005;100(6). [Links]
12. Vuorela P, Leinonen M, Saikku P, Tammela P, Rauha J-P, Wennberg T, et al. Natural Products in the Process of Finding New Drug Candidates. Current Med Chem. 2004;11:1375-89. [Links]
13. Nakanishi K. An historic perspective of Natural Products Chemistry. En: Barton D, Nakanishi K, Mett-Cohn O, editors. Preface to Comprehensive Natural Products Chemistry. Vol. 1-8; 1999. p. 21-38. [Links]
14. Farnsworth NR. Biological and phytochemical screening of plants. J Pharm Sci. 1966;55:225-76. [Links]
15. Segelman AB, Farnsworth NR, Quimby MW. Biological and phytochemical evaluation of plants. III: False-negative saponin test results induced by the presence of tannins. Lloydia. 1968;32:52-8. [Links]
16. Roper EC, Blomster RN, Farnsworth NR, Draus FJ. Studies on alkaloid detecting reagents. II: Stability and sensitivity of modified Dragendorff's reagents. Planta Med. 1965;13:98-103. [Links]
17. Alemán E, Aurich O, Ezcurra L, Gutiérrez M, Horstmann Chr, López J, et al. Phytochemische Untersuchungen an Pflanzen der Kubanischen Flora. Kulturpflanzen. 1972;19:359-425. [Links]
18. Batista M, Dominicis E, Sarduy R, Hernández de Córdoba H. Tamizaje de alcaloides y saponinas de plantas que crecen en Cuba. I. Moa 1. Rev Cubana Farm. 1994;28(1):58-64. [Links]
19. Hernández de Córdova H, Batista M, Sarduy R. Tamizaje de alcaloides y saponinas de plantas que crecen en Cuba. III. Sierra del Rosario. Rev Cubana Farm. 1995;29 (1):58-64. [Links]
20. Payo A, Oquendo A, Oviedo R. Tamizaje fitoquímico preliminar de plantas que crecen en Holguín. Rev Cubana Farm. 1996;30(2). [Links]
21. Borris J. Natural products research: perspectives from a major pharmaceutical company, Merck Research Laboratories. J Ethnopharmacol. 1996;51:29. [Links]
22. Andrews PR, Borris R, Dagne, Gupta MP, Mitscher LA, Monge A, et al. Preservation and utilization of natural biodiversity in context of search for economically valuable medicinal biota. Pure & Appl Chem. 1996,68(12):2325-32. [Links]
23. Cragg GM, Baker JT, Borris RP, Carte B, Cordell GA, Soejarto DD, et al. Interactions with source countries. Guidelines for members of American Society of Pharmacognosy. J Nat Prod. 1997;60:654-5. [Links]
24. Boyd MR. The position of intellectual property rights in drug discovery and development from natural products. J Ethnopharmacol. 1996;51:17-27. [Links]
25. Timmermann BN. Integrating biodiversity prospecting, drug discovery, conservation and sustainable development: the Latin American experience. En: Chou CH, Shao KT. Eds. Frontiers in Biology: The challenges of Biodiversity, Biotechnology and Sustainable Agriculture. Taipei: Academia Sinica; 1998. p. 247-61. [Links]
26. OPS. Informe del taller de medicinas y terapias tradicionales, complementarias y alternativas en las Américas: políticas, planes y programas; 2002. p. 23. [ Links ]
27. Cragg GM, Boyd M. Drug discovery and development at the National Cancer Institute: the role of natural products of plant origin. En: Balick MJ, Elisabetsky E, Laird SA, editors. Medicinal Plant Resources of the Tropical Forest. New York: Columbia University Press; 1996. p. 101-36. [Links]
28. Cragg GM, Simon JE, Jato JG, Snader KM. Drug discovery and development at the National Cancer Institute: potential for new pharmaceutical crops. En: Janick J, editor. Progress in New Crops. Arlington, VA: ASHS Press; 1996. p.554-60. [Links]
29. Cragg GM, Boyd MR, Cardellina JHII, Newman DJ, Snader KM, McCloud. Ethnobotany and drug discovery: the experience of the US National Cancer Institute developmental therapeutics Program, National Cancer Institute, Bethesda. Chichester: Wiley, Ciba Foundation Symposium; 1994. p. 178-6. [Links]
30. De Smet PAGM. The role of plant-derived drugs and herbal medicines in healthcare. Drugs. 1997;54(6):801-40. [Links]
31. Rastogi RP, Dhawan BN. Research on medicinal plants at the Central Drug Research Institute, Lucknow (India). Indian J Med Res. 1982;76(suppl):27-45. [Links]
32. Munro MHG, Blunt JW, Dumdei EJ, Hickford SJH, Lill RE, Li S, et al. The discovery and development of marine compounds with pharmaceutical potential. J Biotechnol. 1999;70:15-25. [Links]
33. Pieters L, Vlietinck AJ. Bioguided isolation of pharmacologically active plant components, still a valuable strategy for the finding of new lead compounds? J Ethnopharmacol. 2005;100(1-2):57-60. [Links]
34. Farnsworth NR. The role of ethnopharmacology in drug development. En: Chadwick D, Marsh J, editors. Bioactive compound from plants. Chichester: Wiley, Ciba Foundation Symposium 154. 1990;2-21. [Links]
35. Huffman MA. Current evidence for self-medication in primates: A multidisciplinary perspective. Am J Phys Anthropol. 1998;104(S25):171-200. [Links]
36. Huffman MA. Animal self-medication and ethnomedicine: exploration and exploitation of the medicinal properties of plants. Proceedings of the Nutrition Society. 2003;62(2):371-81. [Links]
37. Huffman MA, Elias R, Balansard G, Ohigashi H, Nansen P. L' automédication chez les singes anthropoïdes: une étude multidisciplinaire sur le comportement, le regime alimentaire et le santé. Primatologie. 1998;1:179-204. [Links]
38. Huffman MA, Koshimizu K, Ohigashi H. Ethnobotany and Zoopharmacognosy of Vernonia amygdalina, a medicinal plant used by humans and chimpanzees. En: Caligari PDS, Hind DJN, editors. Compositae: Biology and Utilization. Kew: The Royal Botanical Garden. 1996;2:351-60. [Links]
39. Cousins D, Huffman MA. Medicinal properties in the diet of gorillas - an ethnopharmacological evaluation. African Study Monographs 2002;23:65-89. [Links]
40. Berry JP, McFerren MA, Rodríguez E. Zoopharmacognosy: a «biorational» strategy for phytochemical prospecting. En: Gustine DL, Flores H, editors. Phytochemicals and Health, Rockville: ASPP; 1995. p. 165-78. [Links]
41. Krief S, Huffman MA, Sévenet T, Hladik C, Grellier P, Loiseau PM, et al. Bioactive properties of plant species ingested by chimpanzees (Pan troglodytes schweinfurthii) in the Kibale National Park, Uganda. Am J Primatol. 2006;68(1):51-71. [Links]
42. Kaplan MAC, Gotlieb OR. Busca racional de pricípios ativos em plantas. Interciencia. 1990;15 (1):26-9. [Links]
43. Elisabetsky E, Amador TA, Leal M, Nunes DS. Merging ethnopharmacology with chemotaxonomy: an approach to unveil bioactive natural products. The case of Psychotria alkaloids as potential analgesics. Ci Cul. 1997;49:378-85. [Links]
44. Both FL, Kerber VA, Henriques AT, Elisabetsky E. Analgesic properties of umbellatine from Psychotria umbellata. Pharm Biol. 2002;40:336-41. [Links]
45. Diéguez-Hurtado R, Garrido-Garrido G, Prieto-González S, Iznaga Y, González L, Molina-Torres J, et al. Antifungal activity of some Cuban Zanthoxylum species. Fitoterapia. 2003;4:384-6. [Links]
46. Verpoorte R, Choi YH, Kim HK. Ethnopharmacology and systems biology: A perfect holistic match. J Ethnopharmacol. 2005;100:(1-2):53-6. [Links]
47. Boonstra DA, Rathbone, Bruce NC. Engineering novel biocatalytic routes for production of semisynthetic opiate drugs. Biomol Engineering 2001;18:1841-7. [Links]
48. Gauniyal AK, Rawat AKS, Pushpangadan P. Interactive Meeting for Evidenced-Based Complementary and Alternative Medicines: a Report. Evid Based Complement Alternat Med. 2005;2 (2):249-52. [Links]
49. Borhidi A. Phytogeography and Vegetation Ecology of Cuba. Budapest: Académiai Kiadó; 1991. p. 857. [Links]
50. Vales M, Alvarez A, Montes L, Avila A. Estudio nacional sobre la diversidad biológica en la República de Cuba. Madrid: CESYTA; 1998. [Links]